articleThe Lancet Infectious DiseasesMar 8, 2016Closed access

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Brigham and Women's Hospital · Memorial Hermann–Texas Medical Center · +29 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

689
total citations
FWCI
56.44
Percentile
100%
References
30
Citations per year

Authors

34

Topics & keywords

Keywords
  • Mucormycosis
  • Medicine
  • Clinical endpoint
  • Amphotericin B
  • Adverse effect
  • Internal medicine
  • Surgery
  • Mucorales
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding